Enliven Therapeutics
ELVN
#5218
Rank
A$1.80 B
Marketcap
$38.31
Share price
5.84%
Change (1 day)
80.00%
Change (1 year)

Enliven Therapeutics (ELVN) - Total assets

Total assets on the balance sheet as of June 2024 : A$0.49 B

According to Enliven Therapeutics's latest financial reports the company's total assets are A$0.49 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enliven Therapeutics - Total assets on balance sheet (from 2021 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$0.39 B226%
2022-12-31A$0.12 B-21.47%
2021-12-31A$0.15 B-8.32%
2020-12-31A$0.17 B